Summary
Parkinson's disease (PD) is a result of the loss of dopaminergic neurons in the substantia nigra and is expected to increase the economic burden on patients' families and societies. NEAT1, a long non-coding RNA, is known as a cancer-related gene, however, the role of it in PD remains unclear. The aims of this study are to detect the NEAT1-mediated effects in PD and explore the mechanism of NEAT1 in PD. One group (n = 6) of C57BL/6 model mice were intraperitoneal injected with 1-Methyl-4-phenyl-2, 3, 6-tetrahydropyridine (MPTP), while another group (n = 6) was treated with saline and served as control. Human neuroblastoma cell line SH-
SY5Y was pretreated with 1-Methyl-4-phenylpyridinium (MPP+). Cell viability and
apoptosis, as well as gene expression with different treatments were examined.
Up-regulated NEAT1 was found in MPTP-induced PD mice. Moreover, the NEAT1 expression was positively correlated with the concentration of MPP+. In SH-SY5Y cells stimulated by MPP+, NEAT1 knockdown dramatically promoted cell viability and suppressed cell apoptosis. Additionally, down-regulation of NEAT1 also decreased the ratio of Bax/Bcl-2, the activity of caspase-3, as well as the expression of α-synuclein. Moreover, α-synuclein overexpression could significantly reverse the increase in cell viability and the decrease in cell apoptosis induced by NEAT1 knockdown. The results suggested that the knockdown of NEAT1 will have a protective effect on MPTP-induced PD mice. The mechanism may be related to the dysregulation of α-synuclein.
K E Y W O R D S
α-synuclein, cell line SH-SY5Y, NEAT1, Parkinson's disease SC-35-rich domains, and is the essential component of paraspeckle nuclear. 9 It has documented that NEAT1 has the hallmarks of unspliced, nuclear-restricted, polyadenylated and non-coding and Amyotrophic lateral sclerosis (ALS). [13] [14] [15] [16] However, the molecular mechanism the expression of NEAT1 in PD has not been completely understood.
1-Methyl-4-phenyl-2,3,6-tetrahydropyridine (MPTP) is a neuronal cytotoxicity that could cause PD in humans, and could also could transform into its toxic derivative 1-Methyl-4-phenylpyridinium (MPP+) with the enzyme MAO-B in astrocytes. MPP+ is a neurotoxin that exits astroglia via organic cation transporter 3 or the exteansuronal monoamine transporter, 17, 18 and can trigger mitochondrial fragmentation. Now, MPTP has been widely used to induce PDlike disorder from by promoting neuro-degeneration in animal models 19, 20 and MPP+ is mostly used in SH-SY5Y neuroblastoma cells. 21, 22 Based on the above, this study was undertaken to reveal the capacity of NEAT1 on preventing MPTP/MPP+ induced toxicity in PD and declare the underlying mechanism between them. The findings may provide important clinical therapeutic applications for PD.
| RE SULTS

| The expression of NEAT1 in MPTP-induced PD mice
In order to detect the ratio of TH+ and the expression of NEAT1
in the brain of MPTP-treated mice, MPTP was injected to a set of mice. Figure 1A ,B presents the finding that the t-turn time and the time for location activity was significantly increased in MPTP-induced mice, while the retention time of MPTP-induced mice was significantly decreased ( Figure 1C ). As presented in Figure 1D , the ratio of TH+ cells was dramatically reduced in the brain of MPTP-induced mice compared with control.
Beyond that, the level of NEAT1 expression was significantly 
| Effects of NEAT1 expression on cell viability and apoptosis
To investigate the effect of si-NEAT1 in SH-SY5Y cells, the MPTP-treated cells were transfected with si-NEAT1 and the expression of NEAT1 was measured. According to Figure knockdown reversed the effects that were induced by MPP+.
Furthermore, the content of Dopamine was increased in cells transfected with si-NEAT1 in MPP+ induced SH-SY5Y cells ( Figure 2D ).
| Effects of NEAT1 expression on cell apoptosis
To further investigate the effects of NEAT1 expression on cell apoptosis, the expression and activity of apoptosis-related factors were examined. Apoptotic markers such as Bax/Bcl-2 and caspase-3
were affected by si-NEAT ( Figure 3A ). The level of Bax/Bcl-2 ratio markedly increased in the MPP+ treated group, while NEAT1 knockdown reversed the effects of MPP+ ( Figure 3B ). Additionally, we investigated caspase-3 cleavage activity in SH-SY5Y cells pretreated with MPP+ and transfected with or without si-NEAT1, the results revealed that MPP+ treatment increased caspase-3 cleavage activity, while NEAT1 knockdown significantly decreased it ( Figure 3C ).
Western blot revealed that MPP+ treatment significantly decreased
the expression of pro-caspase3 and increased the cleaved caspase3, while si-NEAT1 transfection reversed the effects of MPP+ ( Figure 3D ).
F I G U R E 2
The effects of si-NEAT1 on the cell viability and apoptosis of SH-SY5Y pretreated with MPP+ (1 mmol/L) for 24 hours. A, si-NEAT1 significantly reduced the expression of NEAT1 in the MPP+ induced SH-SY5Y cells. B, C, MPP+ treatment significantly decreased cell viability but increased cell apoptosis, while NEAT1 knockdown reversed the effects of MPP+. D, MPP+ treatment significantly decreased Dopamine content, while NEAT1 knockdown reversed the effects of MPP+. Values means ± SEM were based on three independent experiments. **P < .01
| Effects of si-NEAT1 on the expression of α-synuclein
α-synuclein, a gene that is associated with pathogenesis of PD, was analyzed in the subsequent experiment. According to Figure 4A , NEAT1 knockdown could significantly suppress α-synuclein at the level of mRNA and protein expression and p-α-synuclein at the level of protein expression ( Figure 4A,B) . Meanwhile, the expression of NEAT1 was positively correlated with the expression of α-synuclein in the brain tissues of the MPTP-induced mice model (R 2 = .7215; P = .032; Figure 4C ).
F I G U R E 3
Effects of NEAT1 on cell apoptosis in SH-SY5Y cells pretreated with MPP+. A, The expression of Bax and Bcl-2 were detected using western blot. GAPDH was shown as an internal standard. B, Effects of NEAT1 on the ratio of Bax/Bcl-2. C, Si-NEAT1 reversed the increasingly activity of caspase-3 in SH-SY5Y cells that induced by MPP+. D, Western blot analysis of caspase-3 cleavage and pro-caspase3 in SH-SY5Y cells pretreated with MPP+. **P < .01 and ***P < .001. GAPDH served as internal control
The effects of NEAT1 on α-synuclein expression. A, NEAT1 knockdown significantly decreased the mRNA expression of α-synuclein. B, Western blot analysis was performed to detect the expression of α-synuclein and p-α-synuclein. C, Positive correlation of α-synuclein expression and NEAT1 expression in vivo. **P < .01. GAPDH served as internal control
| Interaction between NEAT1 and α-synuclein in cell viability and apoptosis
To investigate the effects of α-synuclein overexpression on the NEAT1 regulated cell viability and apoptosis of SH-SY5Y cells, a set of treatments were managed. According to Figure 5 , SH-SY5Y cells pretreated with MPP+ and alternatively with the presence or absence of pc-DNA or pc-DNA-α-synuclein. The results revealed that α-synuclein overexpression significantly reversed the increase of cell viability ( Figure 5A ) and the decrease of cell apoptosis that induced by NEAT1 knockdown ( Figure 5B ). In addition, α-synuclein overexpression also significantly reversed the decrease of the expression of α-synuclein and p-α-synuclein ( Figure 5C ).
| D ISCUSS I ON
In past years, the discovery of MPTP-induced model of PD has profoundly improved our understanding of PD pathogenesis, and provided a help for novel therapies. 23 Afterwards, various research emerged to explore the abundance of PD-related genes, [24] [25] [26] [27] which provided great assistance for PD with new therapies. In our study, a PD-related gene NEAT1 was analyzed. We investigated the effects of NEAT1 on MPP+ pretreated SH-SY5Y cell. MPTP was generally used to establish the PD model. In this study, we found that the MPTP-induced model of PD mice showed significant increased expression of NEAT1 and decreased the number of TH+ cells in the midbrain, indicating an increased number of cell deaths in MPTP-induced mice. MPP+, which was widely used to establish the in vitro PD model, is a neurotoxin that plays an important role in PD study. 28 It has been reported that MPP+ induced SH-SY5Y cells and treated with various antioxidants could prevent the cell apoptosis, 29 and our results also showed that knockdown of NEAT1 suppressed MPP+ induced cells apoptosis and caspase-3 activity. The results confirmed that si-NEAT1 could reverse the neurotoxicity on MPP+ stimulated SH-SY5Y cells. Furthermore, NEAT1 could be used as an important diagnostic marker in PD therapy.
To explore the mechanism of si-NEAT1 that regulates the improvement of toxicity in cells, a set of data were measured and analyzed.
Caspase-3, a protease represents a response of PD and could be used as an attractive target for antiapoptotic therapy in PD. 30 In this study,
F I G U R E 5
The effects of α-synuclein overexpression on cell viability and apoptosis. A, α-synuclein overexpression could significantly reverse the increase of cell viability that induced by NEAT1 knockdown. B, α-synuclein overexpression could significantly reverse the increase of cell apoptosis that induced by NEAT1 knockdown. C, α-synuclein overexpression could significantly reverse the decrease of α-synuclein and p-α-synuclein expression that induced by NEAT1 knockdown. *P < .05 the caspase-3 cleavage activity level was detected and the results revealed that si-NEAT1 reversed the increase of caspase-3 that induced by MPP+ in SH-SY5Y cells. In addition, the protein level of Bax/Bcl-2, which also played a vital role in MPP+ induced apoptotic cell death, 31 was decreased by si-NEAT1. Based on the observation above, we arrived at that si-NEAT1 reversed MPP+ induced cell apoptosis, and the data of caspase-3 as well as the ratio of Bax/Bcl-2 strengthened our understand.
The dysregulated α-synuclein, a gene encoding protein, is a risk factor of PD. 32 It has been reported that α-synuclein could be promoted the synaptic plasticity, neuronal differentiation as well as increase of dopamine release. 21 Decressac et al showed that α-synuclein promoted neurodegeneration in midbrain dopamine neurons. 34 However, the reports about the mechanism of NEAT1 regulation in PD are few documented. In the present study, to investigate the regulatory mechanism, we detected the effects of α-synuclein. Results showed that down-regulation of NEAT1 significantly decreased the expression of α-synuclein, whereas, α-synuclein overexpression could notably reverse the increase of cell viability and the decrease of cell apoptosis that induced by si-NEAT1. Moreover, the expression of α-synuclein and NEAT1 expression showed positive correlation. According to the abovementioned, we inferred that the mechanism of neuroprotection induced by knockdown of NEAT1 might act through regulating α-synuclein expression. However, another study found that dopaminergic neurons can response to the overexpression of α-synuclein, 35 so we assume that NEAT1 regulating PD might partly be affected by the quantity of dopamine and the expression of α-synuclein, but the validity of this assumption needs further clarification.
In summary, we found that MPTP/MPP+ induced PD was protected by NEAT1 knockdown and the protect mechanism might link to α-synuclein expression. The study also broadened the vision for PD therapy through regulating NEAT1 expression.
| ME THODS
| Animals obtained and ethics statement
The present animal experiment protocols were approved by the 
| The ratio of Tyrosine hydroxylase positive (TH+)
The number of TH+ in neurons of midbrain was counted at the seventh day after the animals were injected with MPTP or saline. The TH+ cells from six slides per animal were counted and the average was calculated as the final results.
| RNA extraction and real-time PCR
Total RNA was extracted from brain tissues and SH-SY5Y cells using Trizol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocols. RNA concetration was quantified using Nanodrop (Invitrogen). cDNA was obtained using purified The primers sequence of NEAT1 was presented as follows:
Former: 5′-CAGGATAAGCAGAGCTCGCCAGGTTTA-3′
Reverse: 5′-GGCTCGTTCACCTGTTGTCCTCATTTT-3′
| Cell cultures and transfection
The SH-SY5Y cell line was obtained from the Shanghai Cellbio Biotechnology Company (Shanghai, China). Cells were cultured at 37°C with 5% CO 2 using Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal calf serum.
MPP+ was then added to culture the cells for 24 hours. 
| Western blotting
Protein samples were isolated from tissues or cells using RIPA, and quantified with bicinchoninic acid (BCA). 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was used for resolving the protein in the cellular extracts. Then the separated protein was transferred onto PVDF (polyvinylidene fluoride) membrane. 
| Cell viability
The MTT assay was used for determining the viability of SH-SY5Y cells. A total of 1 × 10 5 cells were planted in a 96-well plate, and the cells were incubated at 37°C with 5% CO 2 for 24 hours. Next, 10 uL of MTT was added into each well and incubated in dark for 4 hours.
Finally, 200 uL of DMSO solution was added for dissolving the crystals. Cell viability was quantified by measuring the absorbance value at 570 nm, and the results were expressed as percentages normalized to the control.
| Flow cytometric analysis
Flow cytometry was performed for detecting the cell apoptosis.
Briefly, SH-SY5Y cells were collected after centrifugation, and the 
| Caspase-3 activity
After MPP+ induced SH-SY5Y cells were treated with si-NC or si-NEAT1, cells were lysed and centrifuged. Then, the supernatant was used to test the activity of Caspase-3 according to the protocols of Caspase-3 Activity Colorimetric Assay Kit (Invitrogen). A fluorescence spectrophotometer (absorbance at 405 nm and 505 nm) was used to measure the Fluorescence intensity.
| High performance liquid chromatography (HPLC)
The content of dopamine was determined using method, as described by Wu et al. 36 Briefly, to modulate the chromatography with the flow velocity of 1 mL/minute, the temperature of 30°C and the OD = 354 nm. Add the samples as described in the Instruction. The column was equilibrated with initial conditions for 10 minutes. The excitation/emission wavelength was detected using fluorescence.
| Pole test
The degree of bradykinesia was detected by Pole test. After pretreatment with MPTP for 2 days, the mice were placed at the top of the pole, and timing was begun. The T-turn time was that time taken for the mice to begin to move to the head down. The T-LA time was when the mice begin to head down to naturally climb to the bottom of the pole. 37 The pole was 8 mm in diameter and 50 cm in height, a wooden ball was on the top of the pole, and the pole was covered with gauze to prevent the mouse from slipping.
| Rota-rod test
The Rota-rod test was performed after the mice were pretreated with MPTP for 2 days. The diameter of the roller was 6 cm. After adaption training with a speed of 20 revolution/min. five times, the speed was changed to 30 r/min. The detailed method was as follows:
the mice were placed in a spinning rod, and the duration time of mice on the rod was recorded.
| Statistical analysis
Data were presented as mean ± standard deviation (SD). The difference among different treatments was assessed using one-way ANOVA, while the difference between two parameters was analyzed using Student's test. P <.05 was considered as statistically significant.
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